MODY, a model of genotype/phenotype interactions in type 2 diabetes;Le MODY: Modèle d'étude d'interactions gé notype/phénotype dans le diabète de type 2

Medecine/Sciences

Volumn 19, Issue 8-9, 2003, Pages 854-859

  Velho, Gilberto ^a   Bellanné Chantelot, Christine ^b   Timsit, José ^c  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; TRANSCRIPTION FACTOR;

AUTOSOMAL DOMINANT INHERITANCE; FAMILIAL DISEASE; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; INSULIN RELEASE; JUVENILE DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW;

EID: 0141428027     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20031989854     Document Type: Review

References (20)

1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-80.
2. Timsit J, Dubois-Laforgue D, Boitard C, Bellané-Chantelot C, Velho G. Physiopathologie, présentation clinique et complications des diabètes de type MODY. In: Actualités néphrologiques. Paris: Flammarion Médecine-Sciences, 2002: 89-98.
3. Velho G, Froguel P, Clément K, et al. Primary pancreatic beta-cell secretory defect caused by mutations in the glucokinase in kindreds of maturity onset diabetes of the young. Lancet 1992; 340: 444-8.
4. Byrne MM, Sturis J, Clément K, et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-30.
5. Velho G, Petersen KF, Perseghin G, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODy-2) subjects. J Clin Invest 1996; 98: 1755-61.
6. Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998; 19: 268-70.
7. Velho G, Blanché H, Vaxillaire M, et al. identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40: 217-24.
8. Pearson ER, Velho G, Clark P, et al. β-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor 1-alpha and glucokinase mutations. Diabetes 2001; 50 (suppl 1): S101-7.
9. Vefho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY-3 locus on chromosome 12q. Diabetes Care 1996; 19: 915-9.
10. Byrne MM, Sturis J, Menzel S, et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY on chromosome 12. Diabetes 1996; 45: 1503-10.
11. Pontoglio M, Sreenan S, Roe M, et al. Defective insulin secretion in hepatocyte nuclear factor 1-α deficient mice. J Clin Invest 1998; 101: 2215-22.
12. Dukes ID, Sreenan S, Roe MW, et al. Defective pancreatic b-cell glycolytic signaling in Hepatocyte Nuclear Factor-1α-deficient mice. J Biol Chem 1998; 273: 24457-64.
13. Vaxillaire M, Abderrahmani A, Boutin P, et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 1999; 274: 35639-46.
14. Pantoglio M, Prié D, Cheret C, et al. HNF-1α controls renal glucose reabsorption in mouse and man. EMBO Rep 2000; 1: 359-65.
15. Isomaa B, Henricsson M, Lehto M, et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 1998; 41: 467-73.
16. Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4 alpha regulates expression of genes required for glucose transport and metabolism. Proc Notl Acad Sci USA 1997; 94: 13209-14.
17. Thomas H, Jaschkowitz K, Bulman M, et al. A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-oriset diabetes of the young. Hum Mol Genet 2001; 10: 2089-97.
18. Shih DQ, Screenan S, Munoz KN, et al. Loss of HNF-1 alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism, Diabetes 2001; 50: 2472-80.
19. Lindner TH, Njolstad PR, Harikawa Y, et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1 beta. Hum Mol Genet 1999; 8: 2001-8.
20. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type 2 diabetes mellitus (MCDY4) linked to IPF1. Not Genet 1997; 17: 138-9.